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Leucine-rich repeats (LRRs) are 20–29-aa-long 
sequences that contain a conserved consensus 
sequence LxxLxLxxN/CxL, where L may be 
replaced by isoleucine, phenylalanine, or val-
ine (Kobe and Kajava, 2001). LRRs provide   
a  structural  framework  for  protein–protein 
interactions (Kobe and Kajava, 2001). Several 
LRR-containing proteins, such as TLRs, NODs, 
and GP1b, are important in innate immunity 
(Tang et al., 2004; Inohara et al., 2005; Lee and 
Kim, 2007). Little is known about the role of 
LRR-containing proteins in adaptive immu-
nity, with the exception of CIITA (MHC class II 
transactivator), the deficiency of which results 
in absent expression of MHC class II mole-
cules and severe immunodeficiency (Cressman 
et al., 1999).
LRRC8A (LRR containing 8A) is a 94-kD 
LRR-containing protein highly conserved be-
tween human and mouse (Sawada et al., 2003). 
LRRC8A spans the cell membrane four times 
and its extracellular C terminus contains 17 LRRs 
(Sawada et al., 2003; Smits and Kajava, 2004).   
A 17-yr-old female patient with congenital facial 
abnormalities, absent B cells, and agammaglob-
ulinemia, but normal numbers of T cells, had   
a  balanced  t(9;20)(q33.2;q12)  translocation, 
resulting in the deletion of the C-terminal 
two-and-a-half LRRs of LRRC8A (91 aa) and 
the addition of 35 aa derived from an intronic 
sequence (Sawada et al., 2003). The truncated 
LRRC8A product was co-expressed with the 
intact product of the normal LRRC8A allele   
at comparable levels (Sawada et al., 2003). Re-
constitution of irradiated recipient mice with 
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Lrrc8a is a ubiquitously expressed gene that encodes a leucine-rich repeat (LRR)–containing 
protein detected at higher levels on the surface of thymocytes than on other immune cells. 
We generated Lrrc8a/ mice to investigate the role of LRRC8A in lymphocyte develop-
ment and function. Lrrc8a/ mice had increased prenatal and postnatal mortality, growth 
retardation, and multiple tissue abnormalities. Lrrc8a/ mice displayed a modest block in  
B cell development but intact intrinsic B cell function. In contrast, both Lrrc8a/ mice and 
Lrrc8a/→Rag2/ bone marrow chimeras exhibited a severe cell-intrinsic block in early 
thymic development, with decreased proliferation and increased apoptosis of thymocytes, 
and impaired peripheral T cell function. Thymic epithelial cells expressed an LRRC8A ligand 
that was critical for double-negative to double-positive thymocyte differentiation and 
survival in vitro. LRRC8A constitutively associated with the GRB2–GAB2 complex and 
lymphocyte-specific protein tyrosine kinase (LCK) in thymocytes. LRRC8A ligation activated 
AKT via the LCK–ZAP–70–GAB2–PI3K pathway, and AKT phosphorylation was markedly 
reduced in the thymus of Lrrc8a/ mice. These findings reveal an essential role for LRRC8A 
in T cell development, survival, and function.
© 2014 Kumar et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
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T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e930 Role of LRRC8A in the immune system | Kumar et al.
protein tyrosine kinase (LCK)–ZAP-70–GAB2–PI3K pathway. 
Our work demonstrates an essential role for LRRC8A in T cell 
development and function.
RESULTS
Lrrc8a is widely expressed and LRRC8A is highly expressed  
on thymocytes compared with other immune cells
Lrrc8a mRNA was detected in all 13 tissues tested (Fig. 1 A). 
We examined cellular expression of LRRC8A using a rabbit 
polyclonal antibody to the C-terminal 18-aa-long peptide of 
LRRC8A, and a mAb, 4D10, directed against the region be-
tween the second and third putative transmembrane domains 
(aa 147–262) of LRRC8A. FACS analysis using these two anti-
bodies readily detected LRRC8A on the surface of 293T cells 
transfected with a vector encoding LRRC8a, but not empty 
vector (Fig. S1 A), indicating that LRRC8A can be ex-
pressed on the cell surface, and that both the N and C termini 
syngeneic CD34+ BM progenitors transduced with a retroviral 
vector overexpressing the mutant LRRC8A resulted in a severe 
block in B cell development at the pro–B cell to pre–B cell tran-
sition and reduced numbers of T cells (Sawada et al., 2003). 
The phenotype was attributed to the dominant negative effect 
of the co-expressed mutant LRRC8A allele (Conley, 2003; 
Sawada et al., 2003). No developmental or functional analysis of 
the T cells was conducted in these mice, and the expression 
level of the mutant protein in hematopoietic cells was not doc-
umented (Sawada et al., 2003).
To understand the role of LRRC8A in the adaptive im-
mune system, we generated Lrrc8a/ mice that expressed no 
LRRC8A protein. Unlike the patient, Lrrc8a/ mice have pe-
ripheral B cells and normal immunoglobulin levels but display 
a severe cell-intrinsic block in thymic development and im-
paired peripheral T cell function. We demonstrate that thymic 
epithelial cell (TECs) express ligands for LRRC8A and that 
LRRC8A ligation activates AKT via the lymphocyte-specific 
Figure 1.  Expression of LRRC8A in C57BL/6 mice and 
survival, morphology, and tissue histology of Lrrc8a/ 
mice. (A) Q-PCR analysis of Lrrc8a mRNA expression in tissues. 
Lrrc8a mRNA levels are expressed relative to Gapdh mRNA levels. 
(B) FACS analysis of LRRC8A surface and intracellular expres-
sion on electronically gated splenic CD3+ cells B220+ cells using 
polyclonal antibody C18. Perm: permeabilized. (C and D) FACS 
analysis of LRRC8A surface expression by subpopulations of 
thymocytes (C) and BM B cells (D) using polyclonal antibody 
C18. (E) FACS analysis of LRRC8A expression on gated splenic 
CD3+ cells B220+ cells from Lrrc8a/ mice and WT littermates. 
(F) Frequency of WT, Lrrc8a+/, and Lrrc8a/ pups obtained 
from the matings of Lrrc8a+/ mice (n = 622 pups). (G) Kaplan-
Meier analysis of survival of 120 F2 offspring born from matings 
of Lrrc8a+/ mice, which included 8 Lrrc8a/, 72 Lrrc8a+/, and 
40 Lrrc8a+/+ littermates. (H) Body weight of Lrrc8a/ mice and 
of Lrrc8a/+ and WT littermates (6 mice per group). (I) Gross 
appearance of WT, Lrrc8a+/, and Lrrc8a/ mice at 5 wk of age. 
(J) Representative H&E-stained tissue sections from skin, skeletal 
muscle, and ovary (bars, 200 µm), and kidney (bars, 100 µm) of 
Lrrc8a/ mice and WT littermates. FC: follicle, CL: corpus lu-
teum. Data are representative of three independent experiments 
with one mouse per group (A, C, and D), six independent experi-
ments with one mouse per group (B and E), two independent 
experiments with 3 mice per group (H and I), and two indepen-
dent experiments with two mice per group (J). Mean and SEM 
are shown in A and H. ***, P < 0.001 (Student’s t test).JEM Vol. 211, No. 5 
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highest surface expression of LRRC8A of all immune cells 
studied. Similar results were obtained for all cell lineages using 
4D10 mAb (unpublished data).
Generation and characterization of Lrrc8a/ mice
The strategy for generating Lrrc8a/ mice is depicted in Fig. S1 
(C–F). LRRC8A was not detectable by immunoblotting 
thymocyte lysates from Lrrc8a/ mice (Fig. S1 G) or by FACS 
analysis of splenic T and B cells from these mice (Fig. 1 E). 
Lrrc8a/ mice were bred for 10 generations on the C57BL/6 
background. Similar findings were obtained in Lrrc8a/ mice 
generated from two independently targeted ES clones.
The frequency of live Lrrc8a/ pups obtained from mating 
Lrrc8a+/ mice was 5.5% (Fig. 1 F). The frequency of Lrrc8a/ 
of the molecule are extracellular, rather than intracellular as has 
been suggested recently (Abascal and Zardoya, 2012). This conclu-
sion was further supported by the observation that 293T cells 
transfected with a C-terminally FLAG-tagged LRRC8A dem-
onstrated surface staining with anti-FLAG mAb (Fig. S1 B). 
FACS analysis using C18 antibody revealed that LRRC8A was 
expressed on the surface of mouse splenic CD3+ T cells, B220+ 
B cells, DX5+ NK cells, CD14+ macrophages, and CD11c+ 
dendritic cells (Fig. 1 B and not depicted). FACS analysis of 
permeabilized splenic T and B cells revealed that a substantial 
amount of LRRC8A was intracellular (Fig. 1 B). Thymocytes 
and B cells in BM expressed surface LRRC8A at all stages 
of development, except for minimal, if any, expression on 
pro–B cells (Fig. 1, C and D). Thymocytes at all stages had the 
Figure 2.  B cell development and function in  
Lrrc8a/ mice. (A and B) FACS analysis (A) and percent-
age (B) of B cell subpopulation in the BM (Immat.: imma-
ture, Recirc.: recirculating). (C–E) Gross appearance and 
H&E staining (bars, 200 µm; C), numbers of B220+ cells in 
spleens (D), and FACS analysis of CD21 and CD24 expres-
sion by sIgM+ cells (E, left), of sIgM and CD21 expression 
by sIgM+CD23+ cells (E, middle), and of CD21 and CD23 
expression by sIgM+ cells (E, right). (F) FACS analysis of 
peritoneal lavage fluid for IgM+CD5+ B1 cells (top) and for 
CD5 and CD11b (bottom), within the gated B220+ cell 
population. (G) 3H-thymidine incorporation in purified 
splenic B cells after anti-IgM, LPS, and anti-CD40 stimula-
tion for 72 h. med.: medium. (H) Serum levels of immuno-
globulin isotypes in 4–6-wk-old Lrrc8a/ mice and WT 
littermates determined by ELISA. (I) IgM and IgG3 serum 
antibody levels after immunization with TNP-LPS and 
TNP-Ficoll. Mice were immunized intraperitoneally with 
10 µg TNP-LPS or 10 µg TNP-Ficoll on day 0 and bled on 
day 14. The level of antigen-specific antibody response in 
mice sera were analyzed by TNP-specific ELISA using  
96-well plates coated with TNP-conjugated BSA at 10 µg/ml 
in PBS. Data are representative of three independent ex-
periments with one mouse per group (A–C, E, and F), two 
independent experiments with three mice per group  
(D and G), six independent experiments with one mouse per 
group in five experiments and one Lrrc8a/ mouse and 
two WT littermates in one experiment (H), and four inde-
pendent experiments with one mouse per group in two 
experiments and two mice per group in two experiments (I). 
ELISAs were run on all samples simultaneously and were 
repeated twice. Each symbol represent mean OD value  
of an individual mouse in H. Mean and SEM are shown  
in B, D, and G–I. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 
(Student’s t test). NS = not significant.932 Role of LRRC8A in the immune system | Kumar et al.
factors to the B cell lymphopenia in Lrrc8a/ mice, we ex-
amined Rag2/ chimeras reconstituted with either Lrrc8a/ or 
WT BM cells. Splenic B cell numbers were similarly decreased 
in Lrrc8a/→Rag2/ chimeras compared with  WT→Rag2/ 
chimeras (11.2 ± 1.8 × 106 versus 47.9 ± 3.6 × 106 cells, n = 3, 
P < 0.01), indicating that the peripheral B cell lymphopenia 
in Lrrc8a/ mice is cell intrinsic.
FACS analysis of splenic B cell subsets (Carsetti et al., 2004) 
revealed comparable percentages of follicular B cells, but mod-
estly decreased percentages of transitional B cells and marginal 
zone B cells in Lrrc8a/ mice compared with WT littermates 
(Fig. 2 E). The numbers and subset distribution of peritoneal 
B220+ B cells were normal in Lrrc8a/ mice (Fig. 2 F).
Splenic B cells from Lrrc8a/ mice proliferated normally 
to anti-IgM, anti-CD40, and LPS (Fig. 2 G). Except for a higher 
level of IgG2a, Lrrc8a/ mice had normal levels of serum IgM, 
IgA, and IgG isotypes (Fig. 2 H) and mounted a normal anti-
body response to the type I T independent (TI) antigen TNP-
LPS and the type II TI antigen TNP-Ficoll (Fig. 2 I). These 
results suggest that LRRC8A plays a minor role in B cell de-
velopment and is important for peripheral B cell homeostasis 
but not B cell function.
LRRC8 deficiency results in decreased thymic  
cellularity and impaired thymocyte viability
The thymus was markedly smaller in Lrrc8a/ mice compared 
with WT littermates (Fig. 3 A) and had an 10-fold reduction 
embryos at E14.5 was 7.9% (n = 38), indicating increased 
early mortality in utero. Lrrc8a/ mice had increased postna-
tal lethality; very few survived beyond 4 wk and none beyond 
16 wk (Fig. 1 G). Lrrc8a/ mice appeared normal at birth, but 
by the end of the first week of life, they showed persistent 
growth retardation (Fig. 1, H and I) although they fed normally. 
Lrrc8a/ exhibited curly hair, hind limb weakness, progressive 
hydronephrosis, and sterility. Histological examination revealed 
epidermal hyperkeratosis, thin skeletal muscle bundles, vacuo-
lated renal tubular cells, and absence of ovarian corpora lutea 
(Fig. 1 J). Lrrc8a+/ mice were comparable in appearance, size, 
and weight to WT littermates (Fig. 1, H and I) and had normal 
tissue histology (not depicted).
LRRC8A deficiency modestly impairs  
B cell development but not function
BM from Lrrc8a/ mice had normal cellularity, modestly 
increased  percentage  of  CD43+B220lowIgM  pro–B  cells, 
and modestly decreased percentages of CD43B220lowIgM 
pre–B cells, CD43B220lowIgM+ immature B cells, and B220hi 
IgMhi recirculating B cells (Fig. 2, A and B). Lrrc8a/ mice   
had small spleens with well-preserved architecture (Fig. 2 C).   
The number of B220+ cells in the spleen was approximately 
fourfold lower in Lrrc8a/ mice compared with WT controls 
(Fig. 2 D). The percentage of splenic B220+AnnexinV+ cells 
was comparable in Lrrc8a/ mice and WT controls (unpub-
lished data). To exclude the potential contribution of extrinsic 
Figure 3.  Decreased thymic cellularity 
and impaired thymocyte viability in  
Lrrc8a/ mice. (A–E) Gross appearance (A), 
cellularity (B), H&E staining (C; bars: (left)  
500 µm; (right) 30 µm; C = cortex, M = medulla; 
red asterisks in the inset indicate pyknotic 
nuclei), TUNEL staining (D, bars = 100 µm) 
with quantitative analysis of TUNEL+ nuclei 
and immunostaining of thymic sections using 
a rabbit antibody that recognizes the p17 
subunit, but not the precursor form, of cas-
pase 3 (E, left; bars = 100 µm) or the rabbit 
anti-caspase 3 antibody combined with anti-
CD3 (E, right; bars = 20 µm; caspase 3, blue 
and CD3, brown) with quantification of the 
results of thymi from Lrrc8a/ mice and  
WT littermates (E). (F–I) Gross appearance  
(F), cellularity (G), H&E staining (H; bars: (left) 
500 µm; (right) 30 µm; C = cortex, M = medulla; 
red asterisks in the inset indicate pyknotic 
nuclei), and TUNEL staining (I; bars = 100 µm) 
with quantitative analysis of TUNEL+ nuclei of 
thymi from Lrrc8a/→Rag2/ (Rag2/ 
mice reconstituted with Lrrc8a/ BM) and 
WT→Rag2/ (Rag2/ mice reconstituted 
with WT BM) BM chimeras. Data are represen-
tative of eight experiments with one mouse 
per group (A and B), and three independent 
experiments with one mouse per group (C–I). 
Mean and SEM are shown in D–E, G, and I.  
**, P < 0.01; ***, P < 0.001.JEM Vol. 211, No. 5 
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chimeras compared with controls (Fig. 4 C). The numbers of 
CD44+CD25 DN1 cells were decreased, but not significantly, 
in thymi from Lrrc8a/→Rag2/ chimeras. Irradiation can 
drive transiently the development of RAG2-deficient thymo-
cytes in a restricted manner generating DP cells that express no 
surface CD3, but no SP cells, in the absence of donor-derived 
hematopoietic cells (Zúñiga-Pflücker et al., 1994). The DP and 
SP cells in the thymi of both chimeras were all CD3+ (un-
published data). Furthermore, irradiated Rag2/ mice did 
not harbor DP or CD3+ thymocytes when examined at 8 wk 
(unpublished data). These results indicate that the defect in 
thymocyte development in Lrrc8a/ mice is cell intrinsic.
The defect in the development of Lrrc8a/ thymocytes 
could be due to increased cell death and/or decreased cell pro-
liferation. The percentage of annexin V+ cells was significantly 
increased in Lrrc8a/→Rag2/ chimeras (Fig. 4 D), consis-
tent with the increased number of apoptotic nuclei noted by 
TUNEL staining. In addition, BrdU incorporation in vivo was 
significantly decreased in thymocytes from Lrrc8a/→Rag2/ 
chimeras compared with controls (Fig. 4 E). Thymocyte prolif-
eration to anti-CD3+IL-2 was significantly decreased Lrrc8a/→
Rag2/ chimeras compared with control chimeras, but prolif-
eration to PMA+ionomycin was comparable in the two groups 
(Fig. 4 F). Thus, LRRC8A expression by thymocytes is essen-
tial for their survival and proliferation.
Lrrc8a/ mice exhibited a more exaggerated block in 
thymocyte development than Lrrc8a/→Rag2/ chimeras 
and a substantial decrease in the percentage of DP cells, re-
flected by a drastic decrease in their number compared with 
WT controls (Fig. 5, A and B). The decreased percentage of DP 
thymocytes and the resulting greater reduction in thymocyte 
numbers in Lrrc8a/ mice compared with Lrrc8a/→Rag2/ 
in cellularity (Fig. 3 B). Examination of H&E-stained thymus 
sections demonstrated effacement of the corticomedullary 
junction and numerous pyknotic and karyorrhectic nuclei in 
Lrrc8a/ mice (Fig. 3 C). TdT-mediated dUTP nick end la-
beling (TUNEL) demonstrated significantly increased num-
bers of apoptotic cells in Lrrc8a/ thymi (Fig. 3 D). This was 
confirmed by the presence of increased numbers of CD3+ cells 
that co-stained for activated caspase 3 (Fig. 3 E). These results 
suggest that LRRC8A is important for thymocyte survival.
To exclude the effect of environmental factors on T cell 
development in Lrrc8a/ mice, we examined thymi from 
Rag2/ chimeras reconstituted with either Lrrc8a/ or WT 
BM cells. Thymi of Lrrc8a/→Rag2/ chimeras were smaller 
and contained approximately fourfold fewer cells compared with 
thymi from WT→Rag2/ control chimeras (Fig. 3, F and G). 
Histological analysis revealed impaired corticomedullary differ-
entiation with increased numbers of karyorrhectic and apoptotic 
nuclei in thymi from Lrrc8a/→Rag2/ chimeras compared 
with thymi from control chimeras (Fig. 3, H and I).
Lrrc8a/ mice have a cell-autonomous  
early block in thymocyte development
The distribution of double negative (DN), double positive 
(DP), and single positive (SP) subsets was comparable between 
Lrrc8a/→Rag2/ and control chimeras (Fig. 4 A). How-
ever, as expected from the reduced thymic cellularity, the 
numbers of CD4CD8 DN, CD4+CD8+ DP, and CD4+ 
and CD8+ SP thymocytes were reduced by approximately 
threefold in Lrrc8a/→Rag2/ chimeras compared with con-
trols (Fig. 4 B). Analysis of DN subsets revealed a significant re-
duction in the numbers of CD44+CD25+ DN2, CD44CD25+ 
DN3, and CD44CD25 DN4 cells in Lrrc8a/→Rag2/ 
Figure 4.  Cell-autonomous defect in thymocyte 
maturation in Lrrc8a/ mice. (A–C) Representa-
tive FACS analysis of thymocytes with the percentage 
of cells found in each quadrant indicated (A), number 
of thymocyte subsets (B), and number of DN cell 
subsets (C) in the chimeras. (D and E) Percentage of 
annexin V+ cells (D) and of BrdU+ cells 3 h after i.p. 
injection of BrdU (E) in total thymocytes from the 
chimeras. (F) 3H-thymidine incorporation in thymo-
cytes from the chimeras in response to medium (med), 
anti-CD3+IL-2, and PMA+ionomycin (P+I) stimula-
tion after 72 h in culture. Data are representative  
of three independent experiments with one mouse 
per group (A–F). Mean and SEM are shown in B–F.  
*, P < 0.05; **, P < 0.01; ***, P < 0.001 (Student’s t test). 
NS = not significant.934 Role of LRRC8A in the immune system | Kumar et al.
LRRC8A deficiency impairs peripheral  
T cell expansion and function
Spleens of Lrrc8a/→Rag2/ chimeras were smaller (Fig. 6 A) 
and had an approximately fourfold decrease in the number of 
CD3+ T cells compared with WT→Rag2/ control chime-
ras (Fig. 6 B). The splenic CD4/CD8 ratio was comparable in 
Lrrc8a/→Rag2/ and control chimeras (Fig. 6 C). Lrrc8a/→
Rag2/ chimeras had a significant decrease in the percentage 
of splenic CD4+CD62LloCD44hi T effector memory cells com-
pared with control chimeras, and a compensatory increase in 
the percentage of CD4+CD62LhiCD44lo naive T cells (Fig. 6 D). 
The proliferation of splenic T cells to immobilized anti-CD3 
was significantly impaired in Lrrc8a/→Rag2/ chimeras 
compared with controls and was not increased by the addi-
tion of anti-CD28 mAb (Fig. 6 E). T cells from Lrrc8a/→
Rag2/ chimeras proliferated normally in response to stimu-
lation with PMA and ionomycin, indicating that they do not 
have a general intrinsic proliferative defect. These results in-
dicate that LRRC8A is important for peripheral T cell expan-
sion and function.
Like Lrrc8a/→Rag2/ chimeras, Lrrc8a/ mice had a 
significant reduction in the number of splenic T cells com-
pared with WT controls, with a normal CD4/CD8 ratio (Fig. 6, 
F and G). The percentage of splenic CD3+Annexin V+ cells 
was comparable in Lrrc8a/ and WT mice (unpublished data). 
chimeras suggest that extrinsic factors exacerbate the cell-
intrinsic thymic phenotype in Lrrc8a/ mice. DP thymocytes 
are exquisitely sensitive to damage by cytokines and hormones 
(Screpanti et al., 1989; Cohen, 1992; Ivanov and Nikolić-Zugić, 
1998; Gruver and Sempowski, 2008). Serum chemistry profile 
and levels of TNF and cortisol levels were normal in Lrrc8a/ 
mice (unpublished data). As in the Lrrc8a/→Rag2/ chi-
meras, the numbers of DN2-DN4, but not DN1, cells were 
significantly lower in Lrrc8a/ mice than in WT controls 
(Fig. 5 C). The distribution of DN1a-e subsets, including the 
DN1a and DN1b early thymic progenitors (ETPs; Porritt et al., 
2004), and the percentage of LinSca1+c-kit+ (LSK) cells in 
the BM which contain thymic multipotent progenitors (Ikuta 
and Weissman, 1992; Schwarz and Bhandoola, 2004) were com-
parable in Lrrc8a/ and WT mice (Fig. 5, D and E). As in 
Lrrc8a/→Rag2/ chimeras, the percentage of annexin V+ 
apoptotic thymocytes was increased and the BrdU incorpora-
tion in thymocytes was decreased significantly in Lrrc8a/ mice 
compared with WT controls (Fig. 5, F and G). The percentage 
of TCR-/ cells and the mean fluorescence intensity of the 
TCR- chain on phenotypically mature thymocytes were 
comparable in Lrrc8a/ mice and WT controls (Fig. 5, H and I). 
Unexpectedly, Lrrc8a/ thymi had a significant increase in 
FOXP3+ regulatory T (T reg) cells by immunohistochemistry 
staining and flow cytometry (Fig. 5, J and K).
Figure 5.  Defective thymocyte development in Lrrc8a/ 
mice. (A) FACS analysis of CD4 and CD8 expression by thymo-
cytes from a 3-wk-old Lrrc8a/ mouse and WT littermate.  
The percentage of cells found in each quadrant is indicated.  
(B and C) Number of DN, DP, and SP thymocytes (B) and of Lineage-
negative DN1, DN2, DN3, and DN4 thymocytes (C) in 3–6-wk-old 
Lrrc8a/ mice and WT littermates. (D) FACS analysis of ETPs 
(DN1a-e) in the thymus. Lineage-negative DN1 thymocytes  
were resolved into ETP subpopulations by staining with c-kit  
and CD24. The percentage of cells found in each gate is indi-
cated. (E) FACS analysis of LinSca1+c-Kit+ cells in the BM.  
(F and G) Percentage of annexin V+ cells (F) and BrdU+ cells 3 h 
after i.p. injection of BrdU (G) in thymocytes from 3–6-wk-old 
Lrrc8a/ mice and WT littermates. (H) Percentage of TCR-/ 
cells in the thymus of Lrrc8a/ mice and WT controls. Each 
symbol represents an individual mouse and the small horizontal 
line indicates the mean. (I) Mean fluorescence intensity (MFI) of 
surface TCR- chain expressed on phenotypically mature thy-
mocytes. (J and K) Immunostain of FOXP3+ cells (bars = 200 µm) 
and its quantitation (J) and percentage of FOXP3+ cells in the 
CD4+ cell population (K) in thymi from of Lrrc8a/ mice and WT 
littermates. Data are representative of six independent experi-
ments with one mouse per group (A, B, C, and H), and three 
independent experiments with one mouse per group (D–G and I–K). 
Mean and SEM are shown in B, C, F, G, and I–K. *, P < 0.05;  
**, P < 0.01; ***, P < 0.001 (Student’s t test). NS = not significant.JEM Vol. 211, No. 5 
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LRRC8A is dispensable for the development  
and function of thymic epithelium
TECs play a critical role in thymic development (Rodewald, 
2008). Because Lrrc8a is ubiquitously expressed, we examined 
TECs from Lrrc8a/ mice. FACS analysis revealed that the 
percentages of CD45classII+BP1+ cortical TECs (cTECs) 
and CD45classII+BP1 medullary TECs (mTECs) among 
CD45 nonlymphoid cells were comparable in Lrrc8a/ 
mice and WT littermates (Fig. 7 A). Immunofluorescence 
staining confirmed the presence of both CK8+CK5 cTECs 
and CK8CK5+ mTECs in Lrrc8a/ thymi (Fig. 7 B); how-
ever, their architectural distribution was abnormal with a very 
thin cortical layer and a disorganized medulla. In spite of the 
However, splenic T cells from Lrrc8a/ mice, like those from 
Lrrc8a/→Rag2/ chimeras, had significantly impaired pro-
liferation to immobilized anti-CD3, which was not increased 
by the addition of anti-CD28 mAb or IL-2 (Fig. 6 H). Analy-
sis of TCR-V CDR3 diversity at 6 wk of age showed partial 
restriction of the T cell repertoire in Lrrc8a/ mice com-
pared with age-matched WT littermates, as indicated by 
skewed distribution for some (25%), but not all, of the 
TCR-V families analyzed (Fig. 6 I). The limited restric-
tion of the TCR repertoire in Lrrc8a/ mice is compatible 
with an abnormal TCR repertoire selection in the thymus 
and/or with abnormal clonal expansion/maintenance in 
the periphery.
Figure 6.  Cell-autonomous defect in peripheral T cell expansion and function in Lrrc8a/ mice. (A–E) Gross appearance (scale = centimeter;  
A), T cell numbers (B), FACS analysis of CD4+ and CD8+ cells in gated CD3+ T cells (C), FACS analysis of CD44 and CD62L expression by gated CD4+ cells and 
percentages of CD4+CD62hiCD44lo naive T cells and CD4+CD62loCD44hi T effector memory cells (D), and proliferation of T cells (E) from spleens of Lrrc8a/→
Rag2/ and control WT→Rag2/ chimeras. (F–H) Splenic T cell numbers (F), FACS analysis of CD4+ and CD8+ cells in gated splenic CD3+ T cells (G), and 
proliferation of splenic T cells (H) from Lrrc8a/ mice and WT control littermates. (I) Spectratyping analysis of CD3 diversity of selected TCR-V families 
in splenic T cells from a 6-wk-old Lrrc8a/ mouse and its WT littermate. med = medium. P + I = PMA+ionomycin. Data are representative of three inde-
pendent experiments with one mouse per group (A–H), and two independent experiments with one mouse per group (I). Mean and SEM are shown in B, D–F, 
and H. *, P < 0.05; ***, P < 0.001 (Student’s t test). NS = not significant.936 Role of LRRC8A in the immune system | Kumar et al.
Specifically, the grafts demonstrated corticomedullary differ-
entiation with generation of SP T cell residents in the medulla 
(Fig. 7 D). Thus, LRRC8A is dispensable for the development 
of TECs and for their ability to support T cell development. 
However, a role for LRRC8A in dendritic cell–thymocyte 
interactions cannot be ruled out.
A ligand for LRRC8A is expressed by TECs and is important 
for the maturation of DN into DP thymocytes
We tested the hypothesis that a ligand for LRRC8A is ex-
pressed by TECs and is important for thymocyte maturation. 
Because of the kidney tubule abnormalities in Lrrc8a/ mice, 
we initially examined whether the human embryonic kidney 
epithelial cell line 293T expresses an LRRC8A ligand. FACS 
analysis revealed increased binding of glutathione S-transferase 
(GST)–LRRC8A343-810 fusion protein (GST-LRRC8A) to 
293T cells, compared with GST (Fig. 8 A). This binding was 
specific because it was displaced by MBP-LRRC8A, but not 
by MBP (Fig. 8 A). Conversely, MBP-LRRC8A bound to 
293T cells and was displaced by GST-LRRC8A but not GST 
(unpublished data). GST-LRRC8A did not bind to spleno-
cytes (Fig. 8 B), further indicating the specificity of its binding 
to 293T cells. GST-LRRC8A bound to WT CD45 TECs, 
but not CD45+ thymocytes, including DN, DP, and SP cells 
(Fig. 8, C and D). Both CD45classII+BP1+ cTECs and CD45 
classII+BP1 mTECs bound GST-LRRC8A (Fig. 8 C). These 
results indicate that an LRRC8A ligand is expressed on non-
hematopoietic cells, including TECs.
The BM-derived stromal cell line OP9 stably transfected 
with the Notch ligand Delta-like 1 (OP9-DL1) supports the 
differentiation and expansion of DN thymocytes into DP cells 
in the presence of IL-7 and Flt-3 ligand (Flt3L; Schmitt and 
Zúñiga-Pflücker, 2002). GST-LRRC8A specifically bound to 
OP9-DL1 (Fig. 8 E). Addition of GST-LRRC8A, but not 
GST alone, significantly inhibited the maturation of WT DN 
thymocytes into DP thymocytes in co-cultures with OP9-DL1 
cells in the presence of IL-7 and Flt-3L (Fig. 8, F and G) and 
resulted in a higher percentage of annexin V+ apoptotic DN 
and DP cells (Fig. 8 H). Inhibition of the DN to DP maturation 
by GST-LRRC8a was dose dependent (Fig. 8 I). These results 
suggest that interaction of LRRC8A in thymocytes with its li-
gand on OP9-DL1 cells is important for the in vitro matura-
tion and survival of DN thymocytes into DP thymocytes.
LRRC8A associates with GRB2, GAB2, and LCK  
and activates AKT in thymocytes via the  
LCK–ZAP-70–GAB2–PI3K pathway
The kinase AKT has been implicated in the survival and pro-
liferation of thymocytes (Chen et al., 2001; Juntilla et al., 2007). 
Given the increased cell death of LRRC8-deficient thymocytes, 
we examined whether LRRC8A activates AKT. Cross-linking 
of LRRC8A with anti-LRRC8A mAb resulted in AKT phos-
phorylation in WT thymocytes (Fig. 9 A), including DN thy-
mocytes (Fig. 9 B). LRRC8A cross-linking failed to cause 
AKT phosphorylation in Lrrc8a/ thymocytes (Fig. 9 C), but 
TCR/CD3 cross-linking caused normal AKT phosphorylation 
architectural abnormalities, mTECs showed signs of maturation 
with expression of autoimmune regulator (AIRE), Claudin-4, 
and the ligand for ulex europeus agglutinin 1 (UEA-1; Fig. 7 C). 
Implantation of fetal thymic tissue from WT and Lrrc8a/ 
mice into the kidney subcapsular region of 5-wk-old con-
genic mice supported comparable thymocyte development. 
Figure 7.  LRRC8A is dispensable for the development and function 
of thymic epithelium. (A) FACS analysis of MHC class II and BP-1 ex-
pression by CD45 cells. Numbers represent the percentage of cells.  
(B) Immunofluorescence staining of thymic sections (scale bars = 100 µm) 
for the cTEC antigen CK8, the mTEC antigen CK5, and the nuclear marker 
DAPI. (C) Expression of AIRE, claudin-4, and UEA-1 in thymi from  
Lrrc8a/ and WT littermates (scale bars = 50 µm). (D) Immunofluorescence 
staining of WT and Lrrc8a/ fetal thymi 8 wk after engraftment into the 
renal subcapsular space of WT recipient mice (bars = 100 µm). Data are 
representative of three independent experiments with one mouse per 
group (A–D). Mean and SEM are shown in A. NS = not significant.JEM Vol. 211, No. 5 
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structurally different SRC kinase inhibitors PP2 and SU6656, 
and SYK/ZAP-70 inhibitors Piceatannol and R406, but not 
the MEK1/2 inhibitor GSK1120212, blocked LRRC8A-
driven AKT phosphorylation in thymocytes (Fig. 9 J and not 
depicted). Furthermore, LRRC8A-driven AKT phosphory-
lation was diminished in Zap70/ thymocytes (Fig. 9 K). 
These results indicate that LRRC8A constitutively associates 
with the GRB2–GAB2 complex and LCK, and activates AKT 
via the LCK–ZAP-70–GAB2–PI3K pathway.
We examined whether the lack of LRRC8A impairs 
AKT phosphorylation in thymocytes. Immunostaining sec-
tions of thymi fixed immediately after sacrifice revealed the 
presence of pAKT throughout the thymus in WT mice, with 
the subcapsular area giving the highest signal, but less intense 
pAKT staining in the thymus in Lrrc8a/ mice (Fig. 10 A). 
pAKT staining was specific because it was abolished by prein-
cubation with the specific phosphopeptide used for immuni-
zation (Fig. 10 B). Compared with WT thymi, Lrrc8a/ thymi 
had a reduced percentage of pAKT-positive thymocytes, and 
a lower pAKT/AKT staining intensity ratio with a normal 
in these cells. LRRC8A-driven AKT phosphorylation in WT 
thymocytes was completely inhibited by LY294002 (Fig. 9 A), 
indicating that it was dependent on PI3 kinase (PI3K).
Both intracellular loops of LRRC8A lack the YXXM 
binding motif for binding PI3K. Receptors whose intracellu-
lar domain lacks this motif activate AKT by associating with 
the GRB2–GAB2 complex (Gu and Neel, 2003; Caron et al., 
2009). GAB2 associates with the SRC kinases and is tyrosine 
phosphorylated by these kinases and ZAP-70 (Gu and Neel, 
2003; Palacios and Weiss, 2007) on Y452. This residue is part of 
the YXXM motif in GAB2 that recruits the p85 regulatory 
subunit of PI3K by interacting with its SH2 domain (Nishida 
et al., 1999; Zhao et al., 1999; Crouin et al., 2001). The first 
intracellular loop of LRRC8A contains a proline-rich region 
that could potentially interact with the SH3 domain of the 
adaptor GRB2 and SRC kinases. LRRC8A was found to be 
constitutively associated in thymocytes with GRB2, GAB2, 
and LCK (Fig. 9, D–F). Furthermore, LRRC8A ligation on 
thymocytes caused tyrosine phosphorylation of GAB2 at resi-
due Y452, LCK, and its substrate ZAP-70 (Fig. 9, G–I). The 
Figure 8.  DN thymocyte maturation requires interaction of LRRC8A with a ligand expressed on TECs. (A–D) FACS analysis of the binding of 
GST-LRRC8A fusion protein to 293T cells (A), splenocytes (B), electronically gated CD45+ and CD45 thymus cells, CD45MHCII+BP-1+ cTECs and 
CD45MHCII+BP-1 mTECs from WT mice (C), DN, DP, and SP thymocytes from WT mice (D), and the OP9-DL1 stromal cell line (E). (F–H) FACS analysis of 
CD4 and CD8 expression by purified CD4CD8 DN thymocytes from WT mice after 4 d after co-culture with OP9-DL1 cells in the presence of medium, 
GST-LRRC8A, or GST as control (F), quantitation of the percentages and numbers of CD4+CD8+ DP cells recovered (G), and percentage of apoptotic cells in 
the DN and DP populations at the end of the 4 d co-culture as measured by Annexin V staining followed by flow cytometry (H). (I) Dose response curve of 
the effect of GST-LRRC8A on the in vitro differentiation of DN thymocytes co-cultured with OP9-DL1 cells. DN thymocytes were cultured on OP9-DL1 
cells with GST or GST-LRRC8A at the indicated doses. The graph depicts frequency of DN cells after 4 d of culture. Data are representative of six indepen-
dent experiments with one sample (A) and one mouse (B) per group, three independent experiments with one mouse per group (C and D), and one sample 
per group (E), and three independent experiments with three samples per group (F–I). Mean and SEM are shown in G–I. ***, P < 0.001 (Student’s t test).938 Role of LRRC8A in the immune system | Kumar et al.
indicating that the runting and premature death of Lrrc8a/ 
mice is likely due to their multiple organ abnormalities.
Our studies demonstrate that LRRC8A activates AKT via 
the LCK–ZAP-70–GAB2–PI3K pathway. LRRC8A consti-
tutively associates with the GRB2–GAB2 complex and LCK. 
These associations may be direct, via interactions between 
the proline-rich region in the first intracellular domain of 
LRRC8A and the SH3 domain of GRB2 and LCK, and/or 
indirectly via the interaction of GAB2 with GRB2 and LCK 
(Gu and Neel, 2003). LRRC8A ligation caused phosphoryla-
tion of LCK and its substrate ZAP-70, and of their target GAB2 
at residue  Y452, which, when phosphorylated, recruits PI3K to 
GAB2. The recruited PI3K undergoes phosphorylation by 
LCK and triggers AKT phosphorylation. LRRC8A-mediated 
activation of AKT was blocked by SRC, SYK/ZAP-70, and 
PI3K inhibitors. Thymocytes express both LCK and FYN. 
They also express both SYK and ZAP-70, with SYK expres-
sion highest in DN thymocytes and ZAP-70 expression high-
est in SP thymocytes (Chu et al., 1998; Palacios and Weiss, 
2007). LRRC8A could use different SYK and SRC family ki-
nase members to activate AKT.
AKT phosphorylation was markedly reduced in thymo-
cytes from Lrrc8a/ mice compared with thymocytes from 
WT controls. Given the established role of AKT in thymo-
cyte survival, proliferation, and metabolism (Chen et al., 2001; 
percentage of AKT-positive thymocytes (Fig. 10, C and D). 
The decreased AKT phosphorylation in Lrrc8a/ thymi is spe-
cific because Lrrc8a/ and WT thymi had comparable stain-
ing for pSTAT3 and STAT3 (Fig. 10, E and F). The percentage 
of thymocytes that stained with pAKT, but not of those that 
stained with AKT, was also markedly reduced in thymi from 
Lrrc8a/→Rag2/ chimeras compared with those from con-
trol chimeras (Fig. 10 G).
DISCUSSION
The present study demonstrates that LRRC8A plays a critical 
cell-autonomous role in T lymphocyte development and func-
tion. The thymus of Lrrc8a/→Rag2/ chimeras, like that of 
Lrrc8a/ mice, had decreased cellularity, disorganized architec-
ture, increased apoptosis, and decreased proliferation, indicating 
that these defects are T cell intrinsic. The decreased prolifer-
ation of thymocytes from Lrrc8a/→Rag2/ chimeras to 
anti–CD3+IL-2, but not to the TCR-independent stimuli 
PMA+ionomycin, suggests that LRRC8A signaling contributes 
to TCR-driven thymocyte proliferation. The numbers of thymo-
cytes at the DN2 stage and beyond were significantly reduced 
in Lrrc8a/→Rag2/ chimeras, as in Lrrc8a/ mice, indicat-
ing that the early block in thymocyte development is cell auton-
omous. Despite their defective T cell development and function, 
Lrrc8a/→Rag2/ chimeras had no increase in mortality, 
Figure 9.  LRRC8A associates with GRB2, 
GAB2, and LCK, and activates AKT via the 
LCK–ZAP-70–GAB2–PI3K pathway in  
thymocytes. (A) AKT phosphorylation in WT 
thymocytes after LRRC8A ligation and the 
effect of the PI3 kinase inhibitor LY294002 on 
LRRC8A-mediated AKT phosphorylation. AKT 
phosphorylation in thymocytes pretreated 
with LY294002 or DMSO was determined by 
immunoblotting after LRRC8A ligation for the 
indicated times. (B) Immunoblot analysis of 
the phosphorylation of AKT in total DN thy-
mocytes from WT mice after anti-LRRC8A 
stimulation. (C) AKT phosphorylation in thy-
mocytes from Lrrc8a/ mice in response to 
anti-LRRC8A and anti-CD3 cross-linking. 
CD3-stimulated WT thymocytes were used as 
controls. (D–F) Co-immunoprecipitation of 
LRRC8A with GRB2 (D), GAB2 (E), and LCK  
(F). Ctrl. = control. The asterisk in D indicates a 
nonspecific band in the control IgG lane. The 
total cell lysates were prepared from WT thy-
mocytes. LRRC8A immunoprecipitates were 
immunoblotted for GRB2, and GAB2 and LCK 
immunoprecipitates were immunoblotted for 
LRRC8A. Isotype-matched irrelevant antibod-
ies were used in immunoprecipitation as con-
trols. (G–I) Phosphorylation of GAB2 (G), LCK (H), 
and ZAP-70 (I) after LRRC8A ligation on thymocytes. (J) AKT phosphorylation after LRRC8A ligation of thymocytes pretreated with the SRC kinase inhibi-
tor PP2, the MEK1/2 inhibitor GSK1120212, and the SYK/ZAP-70 inhibitor Piceatannol. (K) LRRC8A- and TCR/CD3-driven AKT phosphorylation in thymo-
cytes from WT or Zap70/ mice after LRRC8A or TCR/CD3 ligation. Data are representative of three independent experiments with cells derived from one 
mouse per experiment (A, B, and D–J), and two independent experiments with cells derived from one mouse per group (C and K). The numbers below the 
blots in A, C, and J represent the mean ratio of pAKT/AKT in two (C) and three (A and J) experiments.JEM Vol. 211, No. 5 
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A ligand for LRRC8A was detected on TECs and on   
the stromal cell line OP9. A fusion protein containing GST 
and the extracellular domain of LRRC8A inhibited OP9-
DL1 cell–dependent maturation of DN cells into DP cells 
in vitro. This finding, together with the decreased pAKT con-
tent of the thymus in Lrrc8a/ mice, suggests that the puta-
tive LRRC8A ligand expressed by TECs delivers a critical 
survival signal via AKT to thymocytes. In addition to 293T 
cells, GST-LRRC8A bound to keratinocytes and fibroblasts 
(unpublished data), suggesting that disruption of LRRC8A   
interaction with a ligand expressed by epithelial and mesen-
chymal cells may contribute to the tissue pathology in Lrrc8a/ 
mice. Identification of this ligand is currently the subject   
of investigation.
The reduced number of T cells and decreased percentage 
of CD4+ T effector memory cells in the spleen of Lrrc8a/→
Rag2/  chimeras  suggest  that  cell-intrinsic  expression  of 
LRRC8A in T cells is important for their homeostatic expan-
sion in the periphery. The decreased proliferation of splenic   
T cells from these chimeras in response to TCR/CD3 liga-
tion, but intact response to PMA+ionomycin, suggest that 
LRRC8A delivers a co-stimulatory signal to antigen-activated   
T cells. Indeed, ligation of LRRC8A causes AKT activation 
in normal splenic T cells (unpublished data), as it does in thy-
mocytes. Lack of LRRC8A-driven AKT activation and/or 
maturation in an abnormal thymic environment may contrib-
ute to the decreased homeostatic proliferation and impaired 
function of LRRC8A-deficient peripheral T cells. Selective 
deletion of Lrrc8a in mature T cells is needed to distinguish 
between these two possibilities.
Juntilla et al., 2007), the significant reduction in tonic AKT 
phosphorylation may play an important role in the defective 
thymic maturation of Lrrc8a/ mice. Decreased AKT activa-
tion could also explain the relative increase in CD4+FOXP3+ 
cells in thymus of these mice because AKT inhibits the gen-
eration of these cells (Haxhinasto et al., 2008; Merkenschlager 
and von Boehmer, 2010). The block in thymocyte maturation 
occurs earlier in Lrrc8a/ mice than in Akt1//Akt2/ 
mice, in which the DN3:DN4 transition is blocked (Juntilla 
et al., 2007). This could be explained by the fact that thymo-
cytes from Akt1//Akt2/ still express Akt3 (Juntilla et al., 
2007) and that LRRC8A ligation may deliver signals in addi-
tion to AKT that are important for thymocyte development 
and survival.
In addition to Akt, several genes have been implicated in 
early thymic development. They include Notch 1 and its down-
stream targets Hes1, Deltex, Nrap, and pTCR (Deftos et al., 
1998, 2000; Krebs et al., 2001; Lamar et al., 2001), as well as 
Bcl-2 (Deftos et al., 1998) and Bcl11b (Wakabayashi et al., 2003; 
Li et al., 2010). qPCR analysis revealed that the expression of 
these genes was either unaffected, or in a few cases increased, in 
DN1-DN4 thymocytes from Lrrc8a/ mice compared with 
WT littermates (unpublished data). IL-7R signaling is impor-
tant for the survival of early thymocytes (Peschon et al., 1994; 
Akashi et al., 1997; Kim et al., 1998). Surface expression of 
IL-7R by thymocyte subpopulations (DN1-4, DP, and SP) 
was comparable between Lrrc8a/ mice and controls (unpub-
lished data). These results rule out a role for abnormalities in 
the above pathways in the thymic developmental block caused 
by LRRC8A deficiency.
Figure 10.  Lack of LRRC8A impairs AKT phosphoryla-
tion in thymocytes. (A–G) Immunostain for pAKT and AKT 
(A; bars = 30 µm), pAKT staining of WT thymus with anti-
pAKT antibody in the absence or presence of the immuniz-
ing phosphopeptide (B; bars = 50 µm), percentage of 
pAKT-positive and AKT-positive cells (C), and pAKT/AKT 
staining intensity ratio (D) in thymic sections from 3-wk-old 
Lrrc8a/ mice and WT littermates. (E and F) Staining for 
pSTAT3 and STAT3 (E; bars = 30 µm), and percentage of 
pSTAT3-positive and STAT3-positive cells (F) in thymic sec-
tions from 3-wk-old Lrrc8a/ mice and WT littermates.  
(G) Immunostain for pAKT and AKT (bars = 50 µm). Thymic 
tissue sections derived from Lrrc8a/→Rag2/ and  
WT→Rag2/ chimeras generated as in Fig. 3 were immuno-
stained with pAKT and AKT specific antibodies. Data are 
representative of three independent experiments with one 
mouse per group (A, C, and D), and two independent experi-
ments with one mouse per group (B and E–G). 200–300 
cells in each group were counted in E. Mean and SEM are 
shown in C, D, and F. ***, P < 0.001 (Student’s t test).  
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eosin staining and immunohistological analysis. In brief, sections were de-
waxed, rehydrated, and endogenous peroxidase activity blocked by 0.3% H2O2/ 
methanol. Heat-induced antigen retrieval was performed when needed. 
Single immunostains were revealed by Real EnVision rabbit or mouse 
HRP Labeled Polymer system (Dako) or by preabsorbed biotinylated rab-
bit anti–rat mouse Ab (1:200; Vector), followed by Streptavidin (SA)-HRP 
conjugated and Diaminobenzidine (DAB; Dako), and nuclei were counter-
stained with hematoxylin. Bright field double immunostains were performed   
using Real EnVision Rabbit HRP (Dako) and MACH4 Universal AP Poly-
mer kit (Biocare Medical) for the detection of CD3 and Caspase 3, respec-
tively, and developed by either DAB or Ferangi Blue (DAKO). Nuclei were 
counterstained with methyl green. Double immunofluorescence analysis has 
been performed using secondary swine anti–rabbit FITC-conjugated anti-
body (1:30; Dako) for CK5 and rabbit anti–rat biotinylated antibody (1:200; 
Vector Laboratories), followed by Streptavidin–Texas red (1:100; Southern-
Biotech) for CK8. Sections were then counterstained with DAPI. Digital 
images were acquired by a DP70 camera (Olympus) mounted on a Bx60 mi-
croscope (Olympus), using CellF Imaging software (Soft Imaging System 
GmbH). The following primary antibodies were used: rabbit anti-caspase 
3 active (clone AF835, 1:600; R&D Systems), anti-CD3 (clone 2C11-145, 
1:100; Dako), anti–cytokeratin-5 (clone D5/16 B4, 1:100; Covance), anti-
AIRE (provided by P. Peterson, University of Tartu, Tartu, Estonia; 1:2,000), 
anti-pAKT (Ser 473; clone 736E11, 1:30; Cell Signaling Technology), anti-
AKT (clone 11E7, 1:100; Cell Signaling Technology), anti-pSTAT3 (Tyr 705; 
clone D3A7, 1:80; Cell Signaling Technology), STAT3 (clone 79D7, 1:100; Cell 
Signaling Technology), rat anti–cytokeratin 8 (clone TROMA-I, 1:200; De-
velopmental Studies Hybridoma Bank), anti-FOXP3 (clone F9, 1:100; Santa 
Cruz Biotechnology, Inc.), and mouse anti-CL4 (clone 3E2C1, 1:100; Invit-
rogen). In addition, biotinylated UEA-1 ligand (1:600; Vector Laboratories) 
was used to detect mature mTECs. The pAKT peptide used for immuniza-
tion was used as a blocking peptide (Cell Signaling Technology) as a con-
trol for pAKT specificity.
Preparation of cells and flow cytometry. Single-cell suspensions from BM, 
thymus, and spleen of 3–6-wk-old mice were prepared as described earlier (de la 
Fuente et al., 2006). TECs were prepared as described by Gray et al. (2002).
Cells were stained with the appropriate fluorochrome-labeled mAbs and 
analyzed on a FACSCalibur or FACSCanto (BD). Fluorescent-labeled or bi-
otinylated monoclonal antibodies to B220 (clone RA3-6B2), BP-1 (clone 
6C3), CD3 (clone 145-2C11), CD4 (clone L3T4), CD8 (clone 53–6.7), 
CD11b (clone M1/70), CD11c (clone N418), CD21/35 (clone eBio8D9), 
CD23 (clone B3B4), CD24 (clone M1/69), CD25 (clone 3C7), CD43 
(clone  eBioR260),  CD44  (clone  IM7),  CD62L  (clone  MEL-14),  CD71 
(clone R17217), CD127 (clone A7R34), c-kit (clone 2B8), FOXP3 (clone 
FJK-16s), IgD (clone 11-26C), IgM (clone eB121-15F9), Sca-1 (clone D7), 
Ter-119 (clone Ter119), and Thy1.2 (clone 30-H12) were purchased from 
eBioscience. Anti–TCR- (clone H57-597) was purchased from BD. Lineage-
negative cells were identified by excluding cells stained with single fluoro-
chrome-labeled cocktail of biotinylated B220 (clone RA3-6B2), CD3 (clone 
145-2C11), CD4 (clone L3T4), CD8 (clone 53–6.7), CD11b (clone M1/70), 
CD11c (clone N418), and Ter-119 (clone Ter119). Annexin-V staining kit 
from BioVision was used for the detection of apoptotic cells. Anti-FLAG 
mAb (clone M2) was purchased from Sigma-Aldrich. Intracellular staining 
was done as per the instructions provided with Cytoperm/Cytofix cell per-
meabilization and staining kit (BD).
BrdU incorporation assays. Mice were injected intraperitoneally with 1 mg 
BrdU in 100 µl 1× PBS and, 3 h later, tissues were harvested and BrdU incor-
poration was analyzed by using a BrdU Flow kit (BD).
Thymus transplantation and immunofluorescence. Individual thymus 
lobes from E14.5–18.5 WT and Lrrc8a/ embryos were transplanted under 
the kidney capsule of anesthetized recipient mice. For staining cryosections, 
thymi were harvested, fixed in phosphate-buffered l-lysine with 1% parafor-
maldehyde/periodate (PLP), dehydrated in 30% sucrose in PBS, snap-frozen 
Lrrc8a/ mice had a modest block in B cell development 
and normal B cell function. However, Lrrc8a/ mice and 
Lrrc8a/→Rag2/ chimeras had a fourfold decrease in splenic 
B cells, suggesting that LRRC8A is important for peripheral 
B cell homeostasis. Ligation of LRRC8A caused AKT phos-
phorylation in B cells (unpublished data), and AKT is impor-
tant for maintaining normal numbers of peripheral B cells 
(Juntilla et al., 2007). Thus, loss of LRRC8A-mediated AKT 
activation in B cells may have contributed to the peripheral   
B cell lymphopenia in Lrrc8a/ mice.
In contrast to the Lrrc8a/ mouse, the patient with the 
heterozygous LRRC8A mutation had no circulating B cells 
and agammaglobulinemia but normal numbers of circulating 
T cells (Sawada et al., 2003). The function of these T cells was 
not tested, but no opportunistic infections were reported in the 
patient despite an age of 17 yr. The difference in the two phe-
notypes most likely reflects the difference between the presence 
of a truncated mutant protein in the patient, which is thought 
to have acted as dominant negative (Conley, 2003; Sawada et al., 
2003), and the complete absence of the protein in the knock-
out mouse. Given the 99% aa sequence homology between 
human and mouse LRRC8A, loss of LRRC8A expression in 
humans would likely present as severe combined immunodefi-
ciency associated with multiple organ abnormalities.
MATERIALS AND METHODS
Generation of Lrrc8a/ mice. We designed a gene-targeting construct for 
replacing the exon 3, which encodes the first 719 aa of LRRC8A. DNA 
fragments 4.809 and 3.375 kb in length were PCR amplified from a BAC 
clone DNA encoding the entire Lrrc8a gene (RP23-315H12) and cloned 5 
and 3 in the pLNTK gene targeting vector. The linearized targeting con-
struct was then electroporated into CJ7 ES cells, which were then selected in 
medium containing 0.4 mg/ml G418 and 10 mg/ml Gancyclovir. Of the 
three ES clones identified with targeted deletion of one of the two alleles of 
Lrrc8a, two were injected into C57BL/6 blastocysts for the generation of 
chimeric mice. ES cell clones and mice were genotyped by Southern blot 
and PCR. The LoxP-flanked neo selection cassette was then removed by 
breeding mice with EII Cre transgenic mice. All mice were kept in a patho-
gen-free environment. All procedures were performed in accordance with 
the Animal Care and Use Committee of the Boston Children’s Hospital. All 
experiments used 4–6-wk-old Lrrc8a/ mice and WT littermates. Due to 
the limited availability of Lrrc8a/ mice and high pre- and postnatal mortal-
ity, many experiments were performed with one Lrrc8a/ and one WT lit-
termate and were repeated at least three times.
Anti-LRRC8A antibodies and immunoblotting. A polyclonal antibody 
(C18) was raised in rabbits against a C-terminal 18-aa-long peptide (NH2-
FSTLPPEVKERLWRADKE-COOH) sequence (aa 791–808) of LRRC8A 
and purified from using LRRC8A peptide Sepharose column chromatography. 
An LRRC8A-specific mouse mAb (4D10) was raised against the first extra-
cellular loop (aa 147–262) of LRRC8A using standard protocols and puri-
fied from ascites by protein G column chromatography. Cell lysates were 
immunoblotted using C18 or 4D10 Abs, followed by HRP-conjugated goat 
anti–rabbit antibody or goat anti–mouse antibody conjugated to horseradish 
peroxidase–HRP and ECL.
Histology, immunohistochemistry, and immunofluorescence. Mouse 
tissue histopathology was performed at the Rodent Histopathology Core 
facility at the Harvard Medical School. TUNEL staining of thymic sections 
was performed as per the instructions of the manufacturer (BD). 2-µm-thick 
formalin-fixed paraffin-embedded sections were subjected to hematoxylin and JEM Vol. 211, No. 5 
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Ly294002 (PI3K inhibitors) were purchased from Sigma-Aldrich. GSK1120212 
(MEK1/2 inhibitor) was purchased from BioVision Technology, Inc. LRRC8A 
and LCK immunoprecipitations were performed as described earlier (de la 
Fuente et al., 2006) using anti-LRRC8A antibodies and anti-LCK mouse 
monoclonal antibody (clone 3A5; Santa Cruz Biotechnology, Inc.), respec-
tively. Cell activation marker expression, thymocytes, and splenic B and T cell 
proliferation and cytokine production assays were performed as described 
previously (de la Fuente et al., 2006).
Serum immunoglobulins and antibody measurements. Serum im-
munoglobulins and antibody levels were determined by previously described 
methods. Mice were immunized with KLH prepared with Imject Alum 
(Thermo Fisher Scientific), TNP-Ficoll, or TNP-LPS (Bio-Rad Laboratories). 
ELISA assays were performed to estimate specific immunoglobulins levels in 
the serum samples of the immunized mice as earlier (de la Fuente et al., 2006).
Quantitative RT-PCR. Total RNA was prepared from the flow cytometri-
cally–sorted WT and KO DN1-4 thymocytes using the RNAqueous extrac-
tion kit (Ambion). RT-PCR was performed using the iScript cDNA synthesis 
kit (Bio-Rad Laboratories). Carboxyfluorescein (FAM)-labeled specific Taq-
Man primers were purchased from Applied Biosystems. Quantitative PCR 
reactions were run on an ABI Prism 7300 sequence detection system plat-
form (Applied Biosystems). The housekeeping gene 2-microglobulin was 
used as a control. The relative gene expression among the different sam-
ples was determined using the method described by Pfaffl (2001). Quan-
tities of all targets in test samples were normalized to the corresponding 
2-microglobulin levels.
Statistical analysis. Statistical analysis of the data using the Student’s t test or 
analysis of variance (ANOVA) was performed with Prism software (Graph-
Pad Software Inc.).
Online  supplemental  material.  Fig.  S1  shows  surface  expression  of   
LRRC8A in untransfected and LRRC8A-transfected 293T cells by FACS 
using LRRC8A and FLAG tag–specific antibodies and the strategy to gener-
ate Lrrc8a/ mice. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20131379/DC1.
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